News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GRAINGER DAVID J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,700 shares
@ $6.47, valued at
$30.4k
|
|
| 07/03/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,290 shares
@ $5.9001, valued at
$25.3k
|
|
| 04/04/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 4,825 shares
@ $3.9, valued at
$18.8k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 7,154 shares
@ $4.25, valued at
$30.4k
|
|
| 01/04/2023 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 2,497 shares
@ $3.1, valued at
$7.7k
|
|
| 10/04/2022 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Sold 2,328 shares
@ $4.0674, valued at
$9.5k
Sold 2,853 shares
@ $3.9501, valued at
$11.3k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Bought 27,500 shares
@ $9.0456, valued at
$248.8k
|
|
| 11/02/2021 |
4
| GRAINGER DAVID J (Chief Innovation Officer) has filed a Form 4 on Centessa Pharmaceuticals plc|
Txns:
| Granted 175,000 options to buy
@ $14.01, valued at
$2.5M
|
|
|
|